Table 2. Results (using baseline estimates of variables).
Strategy | Cost ($) | Effectiveness (QALY) | ICER ($/QALY) over Strategy I |
I. Wait & watch | 19 251 | 10.36 | – |
II. Resect if operable | 32 393 | 9.95 | – 32 054 (Dominated) |
III. EUS-FNA + Cytology + CEA | 25 841 | 11.22 | 6590 (Dominated) |
IV. Integrated mutational profiling | 19 373 | 12.33 | 62 (Preferred) |